Charité – Universitätsmedizin Berlin to Implement BSI Life Sciences Clinical Trial Management Solutions

BSI is pleased to announce that Charité has selected BSI’s Clinical Trial Management System (CTMS) and Electronic Trial Masterfile (eTMF) solutions to support the success of internal and external clinical trials at the prestigious biomedical institution.

Charité is a leading university medicine dedicated to translational research and precision medicine. BSI’s implementation with Charité begins mid-April 2021, with a planned go-live in August 2021.

After a rigorous evaluation, Charité selected BSI thanks to its user-friendly interface and configuration options as well as its efficient, safe, and effective solutions, which are essential to the success of clinical trials.

“The importance of accurate and compliant clinical trial project management and documentation is paramount,” said Dr Alexander Krannich, Head of the Clinical Trial Office, Charité - Universitätsmedizin Berlin. “When it came to choosing a CTMS provider, BSI was the clear winner. BSI’s system offered very broad functionality across its CTMS and eTMF products as well as possibilities for enhancemens by pure configuration to fit our needs. They were able to clearly demonstrate the value, power, and security of their solutions as well as their deep knowledge and focus on compliance and accuracy.”

BSI’s comprehensive, collaborative, and adaptable approach offers customers peace of mind. With BSI, customers know they have invested in a powerful suite of solutions that can flex to meet their needs.

“While institutions such as Charité may not yet require BSI’s full-spectrum services, they have the reassurance that a simple, cost-effective expansion is possible when they need it,” explained Jan Nielsen, Community Manager Life Sciences at BSI. “We’re very pleased to be partnering with Charité Universitätsmedizin on this journey.”

Innovative capacity and responsible governance, for the benefit of patients and society – these are the central tenets behind all of Charité research endeavors. At Charité, approximately 4,693 researchers are actively engaged in the development of pioneering innovations in the field of medicine. Committed to the highest standards of quality and sustainability, they work across 1,000 projects, working groups and collaborative projects. There is a particular focus on the interface between basic and patient-oriented research, which seeks to foster interdisciplinary collaborations with both national and international partners. Harnessing the potential of this approach is of particular importance to Charité given that the most significant scientific developments are likely to arise from interdisciplinary cooperation.